Background:A woman's uterus can be surgically removed during a hysterectomy. The present study was conducted to evaluate the peri- operative and post- operative complications of vaginal and abdominal hysterectomy. Materials & Methods:76 cases undergoing hysterectomywere divided into 2 groups of 38 each. Group I patients underwent abdominal hysterectomy and group II underwent vaginal hysterectomy. Parameters such as operative time, primary haemorrhage, wound infection, hospital stay etc. were recorded. Results: Indication was uterovaginal prolapse in 11 and 13, leiomyoma in 15 and 14, dysfunctional uterine bleeding in 12 and 11 in group I and II respectively. Duration of operation was 85.2minutes and 73.4minutes, mean blood loss was 372.2 ml and 290.5 ml, hospital stay was 3.4days and 2.7days and preoperative haemoglobin was 11.5g/dl and 12.3g/dl in group I and II respectively. The difference was significant (P< 0.05). Complications were secondary haemorrhage in 4 and 2, wound infection in 5 and 1, pyrexia in 1 and 0, re- admission in 5 and 2 and re- opening in 2 and 1 patients in group I and group II respectively. Conclusion: Due to its clear benefits, VH can be administered to all patients with a moderate-sized uterus who need a hysterectomy for benign diseases.